Thompson M.G., Natarajan K., Irving S.A., Rowley E.A., Griggs E.P., Gaglani M., Klein N.P., Grannis S.J., DeSilva M.B., Stenehjem E., Reese S.E., Dickerson M., Naleway A.L., Han J., Konatham D., McEvoy C., Rao S., Dixon B.E., Dascomb K., Lewis N., Levy M.E., Patel P., Liao I.-C., Kharbanda A.B., Barron M.A., Fadel W.F., Grisel N., Goddard K., Yang D.-H., Wondimu M.H., Murthy K., Valvi N.R., Arndorfer J., Fireman B., Dunne M.M., Embi P., Azziz-Baumgartner E., Zerbo O., Bozio C.H., Reynolds S., Ferdinands J., Williams J., Link-Gelles R., Schrag S.J., Verani J.R., Ball S., and Ong T.C. (2022).

Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 States.

Fink R.V., Fisher L., Sulaeman H., Dave H., Levy M.E., McCann L., Di Germanio C., Notari E., Green V., Cyrus S., Williamson P., Saa P., Haynes J.M., Groves J., Mathew S., Kaidarova Z., Bruhn R., Grebe E., Opsomer J., Jones J.M., Miller M.J., Busch M.P., and Stone M. (2022).

How do we...form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?.

Busch M.P., Stramer S.L., Stone M., Yu E.A., Grebe E., Notari E., Saa P., Ferg R., Molina Manrique I., Weil N., Fink R.V., Levy M.E., Green V., Cyrus S., Williamson P.C., Haynes J., Groves J., Krysztof D., Custer B., Kleinman S., Biggerstaff B.J., Opsomer J.D., and Jones J.M. (2022).

Population-weighted seroprevalence from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, vaccination, and hybrid immunity among US blood donations from January to December 2021.

Traverso-Ortiz M., Duran D., Mesnard M., Ng D., and Dailey S. (2022).

Results of year 2 data quality evaluation of CDC's National Program of Cancer Registries: Weighing the evidence, identifying research gaps, and evaluating outputs of a prevention research agenda.

Weeks K.S., Lynch C.F., West M., Carnahan R., O'Rorke M., Oleson J., McDonald M., Stewart S.L., Hunter L.L., Lai S.-M., Garimella S., Keighley J., Huang L., Jackson-Thompson J., Huang L., Hunt Rold N., Schmaltz C.L., Yemane S., Ross W., Ng D., Traverso-Ortiz M., Wike J.M., Thompson T.D., Hee Rim S., Moore A., and Charlton M. (2022).

Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.

Rose R.A., Cosgrove J.A., and Lee B.R. (2022).

Directed acyclic graphs in social work research and evaluation: A primer.

Miller M.J., Himschoot A., Fitch N., Jawalkar S., Freeman D., Hilton C., Berney K., Guy G.P., Benoit T.J., Clarke K.E.N., Busch M.P., Opsomer J.D., Stramer S.L., Hall A.J., Gundlapalli A.V., MacNeil A., McCord R., Sunshine G., Howard-Williams M., Dunphy C., and Jones J.M. (2022).

Association of trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and state-issued nonpharmaceutical interventions: United States, 1 August 2020 to 30 March 2021.

Nelson A.T., Dybvik A., Mallinger P., McQuaid S.W., Watson D., Harney L.A., Stewart D.R., Dehner L.P., Messinger Y.H., Kunin-Batson A.S., and Schultz K.A.P. (2022).

Health-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry.

Tewahade S., Berrigan D., Slotman B.A., Stinchcomb D.G., Sayer R.D., Catenacci V.A., and Ostendorf D.M. (2022).

Impact of the built, social, and food environment on long-term weight loss within a behavioral weight loss intervention.

Schultz K.A.P., Harris A.K., Nelson A.T., Watson D., Lucas J.T., Miniati D., Stewart D.R., Hagedorn K.N., Mize W., Kamihara J., Mitchell S.G., Wilson D.B., Gettinger K., Rangaswami A.A., Harney L.A., Rodriguez Galindo C., Bisogno G., Dehner L.P., Hill D.A., and Messinger Y.H. (2022).

Outcomes for children with Type II and Type III pleuropulmonary blastoma following chemotherapy: A report From the International PPB/DICER1 Registry.

Vanderpool R.C., Huang G., Wilson A., Gordon R., Mollica M.A., and Maynard C.D. (2022).

Childhood cancer information-seeking: Findings from the National Cancer Institute's Cancer Information Service.

Schrag S.J., Verani J.R., Dixon B.E., Page J.M., Butterfield K.A., Gaglani M., Vazquez-Benitez G., Zerbo O., Natarajan K., Ong T.C., Lazariu V., Rao S., Beaver R., Ellington S.R., Klein N.P., Irving S.A., Grannis S.J., Kiduko S., Barron M.A., Midturi J., Dickerson M., Lewis N., Stockwell M.S., Stenehjem E., Fadel W.F., Link-Gelles R., Murthy K., Goddard K., Grisel N., Valvi N.R., Fireman B., Arndorfer J., Konatham D., Ball S., Thompson M.G., and Naleway A.L. (2022).

Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States.

Oh A.Y., Rising C.J., Gaysynsky A., Tsakraklides S., Huang G.C., Chou W.-Y.S., Blake K.D., and Vanderpool R.C. (2022).

Advancing multi-level health communication research: A delphi study on barriers and opportunities.

Casagrande S.S., Avilés-Santa M.L., Sotres-Alvarez D., Gallo L., Simon M., Kominiarek M., Talavera G., Stuebe A.M., Potter J., Perera M.J., Isasi C., Gonzalez J.S., Rust K., and Cowie C. (2022).

Association between gestational diabetes and 6-year incident diabetes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Smith T., Holm R.H., Keith R.J., Amraotkar A.R., Alvarado C.R., Banecki K., Choi B., Santisteban I. C., Bushau-Sprinkle A.M., Kitterman K.T., Fuqua J., Hamorsky K.T., Palmer K.E., Brick J.M., Rempala G.A., and Bhatnagar A. (2022).

Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence.

Sapru S., Green P., Weber M.K., Chansky M., and Price S. (2022).

Evaluating partnerships for practice change in the prevention, identification, and treatment of fetal alcohol spectrum disorders.

Gaglani M., Kim S.S., Naleway A.L., Levine M.Z., Edwards L., Murthy K., Dunnigan K., Zunie T., Groom H., Ball S., Jeddy Z., Hunt D., Wesley M.G., Sambhara S., Gangappa S., Grant L., Cao W., Liaini Gross F., Mishina M., Fry A.M., Thompson M.G., Dawood F.S., and Flannery B. (2022).

Effect of repeat vaccination on immunogenicity of quadrivalent cell-culture and recombinant influenza vaccines among healthcare personnel aged 18–64 Years: A randomized, open-label trial.

Britton A., Embi P.J., Levy M.E., Gaglani M., DeSilva M.B., Dixon B.E., Dascomb K., Patel P., Schrader K.E., Klein N.P., Ong T.C., Natarajan K., Hartmann E., Kharbanda A.B., Irving S.A., Dickerson M., Dunne M.M., Raiyani C., Grannis S.J., Stenehjem E., Zerbo O., Rao S., Han J., Sloan-Aagard C., Griggs E.P., Weber Z.A., Murthy K., Fadel W.F., Grisel N., McEvoy C., Lewis N., Barron M.A., Nanez J., Reese S.E., Mamawala M., Valvi N.R., Arndorfer J., Goddard K., Yang D.-H., Fireman B., Ball S.W., Link-Gelles R., Naleway A.L., and Tenforde M.W. (2022).

Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 omicron predominance — VISION Network, 10 states, December 2021–August 2022.

Tatalovich Z., Stinchcomb D.G., Ng D., Yu M., Lewis D.R., Zhu L., and Feuer E.J.R. (2022).

Developing geographic areas for cancer reporting using automated zone design.

Flerlage J.E., Myers J.R., Maciaszek J.L., Oak N., Rashkin S.R., Hui Y., Wang Y.-D., Chen W., Wu G., Chang T.-C., Hamilton K.V., Goldin L.R., Rotunno M., Caporaso N.E., Vogt A., Flamish D., Wyatt K., Liu J., Tucker M.A., Mullighan C.G., Nichols K.E., Metzger M.L., McMaster M.L., Yang J.J., and Rampersaud E. (2022).

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

Etemadi A., Buller I.D., Hashemian M., Roshandel G., Poustchi H., Espinosa M.M., Blount B.C., Pfeiffer C.M., Keshavarzi B., Flory A.R., Nasseri-Moghaddam S., Dawsey S.M., Freedman N.D., Abnet C.C., Malekzadeh R., and Ward M.H. (2022).

Urinary nitrate and sodium in a high-risk area for upper gastrointestinal cancers: Golestan Cohort Study.

Ferdinands J.M., Rao S., Dixon B.E., Mitchell P.K., DeSilva M.B., Irving S.A., Lewis N., Natarajan K., Stenehjem E., Grannis S.J., Han J., McEvoy C., Ong T.C., Naleway A.L., Reese S.E., Embi P.J., Dascomb K., Klein N.P., Griggs E.P., Konatham D., Kharbanda A.B., Yang D.-H., Fadel W.F., Grisel N., Goddard K., Patel P., Liao I.-C., Birch R., Valvi N.R., Reynolds S., Arndorfer J., Zerbo O., Dickerson M., Murthy K., Williams J., Bozio C.H., Blanton L., Verani J.R., Schrag S.J., Dalton A.F., Wondimu M.H., Link-Gelles R., Azziz-Baumgartner E., Barron M.A., Gaglani M., Thompson M.G., and Fireman B. (2022).

Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 States.

Sugarbaker P.H. and Chang D. (2022).

Lymph node positive pseudomyxoma peritonei.

White J.D., Wyss A.B., Hoang T.T., Lee M., Richards M., Parks C.G., Beene-Freeman L.E., Hankinson J.L., Umbach D.M., and London S.J. (2022).

Residential wood burning and pulmonary function in the Agricultural Lung Health Study.

Kumar V. and Encinosa W.E. (2022).

Revisiting the obesity paradox in healthcare expenditures among adults with diabetes.

Jones J.M., Opsomer J.D., Stone M., Benoit T., Ferg R.A., Stramer S.L., and Busch M.P. (2022).

Updated US Infection- and vaccine-induced SARS-CoV-2 seroprevalence estimates based on blood donations, July 2020–December 2021.

Lartey I., Kravchenko A., Bonito G., and Melakeberhan H. (2022).

Parasitic variability of Meloidogyne hapla relative to soil groups and soil health conditions.

Akselrod H., Byrne M., Lundberg J., Czeresnia J.M., Lucar J., Secco A., Levy M., Monroe A., Castel A., Horberg M., Doshi R., Rivasplata H., Squires L., Parenti D., and Benator D. (2022).

Improvements in virologic control among PWH over time: Narrowing the gap between those with and without STIs.

Treviño M., Zhu X., Lu Y.Y., Scheuer L.S., Passell E., Huang G.C., Germine L., and Horowitz T.S. (2022).

Establishing construct validity of neuropsychological tests in cancer survivors.

Natarajan K., Prasad N., Dascomb K., Irving S.A., Yang D.-H., Gaglani M., Klein N.P., DeSilva M.B., Ong T.C., Grannis S.J., Stenehjem E., Link-Gelles R., Rowley E.A., Naleway A.L., Han J., Raiyani C., Benitez G.V., Rao S., Lewis N., Fadel W.F., Grisel N., Griggs E.P., Dunne M.M., Stockwell M.S., Mamawala M., McEvoy C., Barron M.A., Goddard K., Valvi N.R., Arndorfer J., Patel P., Mitchell P.K., Smith M., Kharbanda A.B., Fireman B., Embi P.J., Dickerson M., Davis J.M., Zerbo O., Dalton A.F., Wondimu M.H., Azziz-Baumgartner E., Bozio C.H., Reynolds S., Ferdinands J., Williams J., Schrag S.J., Verani J.R., Ball S., Thompson M.G., and Dixon B.E. (2022).

Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults.

Klein N.P., Stockwell M.S., Demarco M., Gaglani M., Kharbanda A.B., Irving S.A., Rao S., Grannis S.J., Dascomb K., Murthy K., Rowley E.A., Dalton A.F., DeSilva M.B., Dixon B.E., Natarajan K., Stenehjem E., Naleway A.L., Lewis N., Ong T.C., Patel P., Konatham D., Embi P.J., Reese S.E., Grisel N., Goddard K., Barron M.A., Dickerson M., Liao I.-C., Fadel W.F., Yang D.-H., Arndorfer J., Fireman B., Griggs E.P., Valvi N.R., Hallowell C., Zerbo O., Reynolds S., Ferdinands J., Wondimu M.H., Williams J., Bozio C.H., Link-Gelles R., Azziz-Baumgartner E., Schrag S.J., Thompson M.G., and Verani J.R. (2022).

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5–17 years — VISION Network.

Saa P., Fink R.V., Bakkour S., Jin J., Simmons G., Muench M.O., Dawar H., Di Germanio C., Hui A.J., Wright D.J., Krysztof D.E., Kleinman S.H., Cheung A., Nester T., Kessler D.A., Townsend R.L., Spencer B.R., Kamel H., Vannoy J.M., Dave H., Busch M.P., Stramer S.L., Stone M., Jackman R.P., and Norris P.J. (2022).

Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.

Rohan E.A., Gallaway M.S., Huang G.C., Ng D., Boehm J.E., Samarasinha R., and Stachon K. (2022).

Disparities in psychosocial distress screening and management of lung and ovarian cancer survivors.

Friesen M.C., Hung F., Xie S., Viet S.M., Deziel N.C., Locke S.J., Josse P.R., Sauvé J.F., Andreotti G., Thorne P.S., Beane-Freeman L.E., and Hofmann J.N. (2022).

A task-specific algorithm to estimate occupational (1→3)-ß-D-glucan exposure for farmers in the Biomarkers of Exposure and Effect in Agriculture Study.

Campione J.R., Ritchie N.D., Fishbein H.A., Mardon R.E., Johnson M.C., Pace W., Birch R.J., Seeholzer E.L., Zhang X., Proia K., Siegel K.R., and McKeever Bullard K. (2022).

Use and impact of type 2 diabetes prevention interventions.

Link-Gelles R., Levy M.E., Gaglani M., Irving S.A., Stockwell M., Dascomb K., DeSilva M.B., Reese S.E., Liao I.-C., Ong T.C., Grannis S.J., McEvoy C., Patel P., Klein N.P., Hartmann E., Stenehjem E., Natarajan K., Naleway A.L., Murthy K., Rao S., Dixon B.E., Kharbanda A.B., Akinseye A., Dickerson M., Lewis N., Grisel N., Han J., Barron M.A., Fadel W.F., Dunne M.M., Goddard K., Arndorfer J., Konatham D., Valvi N.R., Currey J.C., Fireman B., Raiyani C., Zerbo O., Sloan-Aagard C., Ball S.W., Thompson M.G., and Tenforde M.W. (2022).

Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated — VISION Network, 10 States, December 2021–June 2022.

Slotman B.A., Stinchcomb D.G., Powell-Wiley T.M., Ostendorf D.M., Saelens B.E., Gorin A.A., Zenk S.N., and Berrigan D. (2022).

Environmental data and methods from the Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures environmental working group.

Caminiti C., Bryce J., Riva S., Ng D., Diodati F., Iezzi E., Sparavigna L., Novello S., Porta C., Del Mastro L., Procopio G., Cinieri S., Falzetta A., Calabrò F., Lorusso V., Cogoni A.A., Tortora G., Maruzzo M., Passalacqua R., Cognetti F., Adamo V., Capelletto E., Ferrari A., Bagnalasta M., Bassi M., Nicelli A., De Persis D., D'Acunti A., Iannelli E., Perrone F., and Mitchell S.A. (2022).

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE).

Bardenheier B.H., Resnik L.J., Jutkowitz E., and Gravenstein S. (2022).

Patterns of limitation in physical function in late midlife associated with late-onset Alzheimer's disease and related dementias: A cluster analysis.

Meehan A., Uth R., Gadbois E.A., Baier R.R., Gravenstein S., Zullo A.R., Kabler H., Loiacono M.M., and Bardenheier B.H. (2022).

Impact of COVID-19 on influenza and infection control practices in nursing homes.

Chaffee B.W., Lauten K., Sharma E., Everard C.D., Duffy K., Park-Lee E., Taylor E., Tolliver E., Watkins-Bryant T., Iafolla T., Compton W.M., Kimmel H.L., Hyland A., and Silveira M.L. (2022).

Oral health in the Population Assessment of Tobacco and Health Study.

Stanton C.A., Tang Z., Sharma E., Seaman E., Gardner L.D., Silveira M.L., Hatsukami D., Day H.R., Cummings K.M., Goniewicz M.L., Limpert J., Everard C., Bansal-Travers M., Ambrose B., Kimmel H.L., Borek N., Compton W.M., Hyland A.J., and Pearson J.L. (2022).

Predictors of e-cigarette and cigarette use trajectory classes from early adolescence to emerging adulthood across four years (2013-2017) of the PATH Study.

Sugarbaker P.H. and Chang D. (2022).

Incomplete cytoreduction of colorectal cancer peritoneal metastases: Survival outcomes by a cytoreduction score.

Mitchell P.K., Wang L., Stanhope B.J., Cronk B.D., Anderson R., Mohan S., Zhou L., Sanchez S., Bartlett P., Maddox C., DeShambo V., Mani R., Hengesbach L.M., Gresch S., Wright K., Mor S., Zhang S., Shen Z., Yan L., Mackey R., Franklin-Guild R., Zhang Y., Prarat M., Shiplett K., Ramachandran A., Narayanan S., Sanders J., Hunkapiller A.A., Lahmers K., Carbonello A.A., Aulik N., Lim A., Cooper J., Jones A., Guag J., Nemser S.M., Tyson G.H., Timme R., Strain E., Reimschuessel R., Ceric O., and Goodman L.B. (2022).

Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of salmonella, escherichia coli and listeria.

Menard J., Goggs R., Mitchell P., Yang Y., Robbins S., Franklin-Guild R.J., Thachil A.J., Altier C., Anderson R., Putzel G.G., McQueary H., and Goodman L.B. (2022).

Effect of antimicrobial administration on fecal microbiota of critically ill dogs: Dynamics of antimicrobial resistance over time.

Borger C., Paolicelli C., Sun B., Zimmerman T.P., and Dixit-Joshi S. (2022).

Duration of WIC participation and early feeding practices are associated with meeting the added sugars recommendation at age 3 years.

Alvarez C., Ibe C., Dietz K., Carrero N.D., Avornu G., Turkson-Ocran R.-A., Bhattarai J., Crews D., Lipman P.D., and Cooper L.A. (2022).

Development and implementation of a combined nurse care manager and community health worker training curriculum to address hypertension disparities.

Cooper M., Day H.R., Ren C., Oniyide O., Corey C.G., Ambrose B.K., Cummings K.M., Sargent J., Niaura R., Pierce J.P., Kaufman A., Choi K., Goniewicz M.L., Stanton C.A., Villanti A., Kasza K., Bansal-Travers M., Silveira M.L., Kimmel H.L., Hull L.C., Koblitz A., Poonai K., Paredes A., Taylor K., Borek N., and Hyland A.J. (2022).

Correlates of tobacco product initiation among youth and young adults between waves 1–4 of the Population Assessment of Tobacco and Health (PATH) Study (2013–2018).

Borger C., Zimmerman T., DeMatteis J., Gollapudi B., Whaley S., Ritchie L., Au L., and May L. (2022).

WIC Infant and Toddler Feeding Practices Study-2: Fifth year report.

Monroe A.K., Xiao J., Greenberg A.E., Levy M.E., Temprosa M., Resnik J.B., and Castel A.D. (2022).

Risk of severe COVID-19 disease and the pandemic's impact on service utilization among a longitudinal cohort of persons with HIV-Washington, DC.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.